Drug interactions
Conivaptan + Dexamethasone-tobramycin
Severity: Moderate
Conivaptan and Dexamethasone-tobramycin: moderate interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Conivaptan inhibits CYP3A4, which could raise dexamethasone levels, while dexamethasone induces CYP3A4 and may reduce conivaptan exposure. Net effects are uncertain and mostly relevant with systemic dexamethasone.
What this interaction means in plain words
Conivaptan and Dexamethasone-tobramycin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Why it happens
Bidirectional CYP3A4 effects: inhibition by conivaptan and induction by dexamethasone.
What to do
Monitor serum sodium response to conivaptan and watch for corticosteroid adverse effects.
What to ask your pharmacist
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Conivaptan and Dexamethasone-tobramycin, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Dexamethasone-tobramycin
Frequently asked questions
Can I take Conivaptan with Dexamethasone-tobramycin?
MediHelp rates the interaction as moderate. Conivaptan and Dexamethasone-tobramycin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Conivaptan inhibits CYP3A4, which could raise dexamethasone levels, while dexamethasone induces CYP3A4 and may reduce conivaptan exposure. Net effects are uncertain and mostly relevant with systemic dexamethasone.
How serious is the interaction between Conivaptan and Dexamethasone-tobramycin?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor serum sodium response to conivaptan and watch for corticosteroid adverse effects.
What other medicines interact with Dexamethasone-tobramycin?
MediHelp also lists interactions of Dexamethasone-tobramycin with, for example, Capreomycin, Carboplatin, Ciprofloxacin. The full list is on the Dexamethasone-tobramycin page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
